Related Experiment Video
Updated: Feb 11, 2026

05:47
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
8.1K
Development and testing of a self-regulation model for recurrent depression
Bonnie M Hagerty1, Melissa A Bathish1, Emily Kuchman1
1University of Michigan, USA.
Journal of Health Psychology
|May 4, 2018
Summary
A new intervention for depression management, Self-Regulated Illness Management of Depression, proved feasible and useful. It significantly reduced depressive symptoms in participants with recurrent depression six months post-intervention.
Area of Science:
- Psychology
- Clinical Psychology
- Mental Health
Background:
- Self-regulation is a key strategy for managing depression.
- Developing effective self-management interventions is crucial for recurrent depression.
Purpose of the Study:
- To describe the development of a novel intervention based on metacognition and self-regulation for depression.
- To assess the feasibility and utility of this intervention.
- To determine the intervention's effectiveness in reducing depressive symptoms.
Main Methods:
- The Self-Regulated Illness Management of Depression intervention was developed.
- The intervention was delivered to 22 participants diagnosed with recurrent depression.
- Feasibility, utility, and depressive symptom reduction were assessed at 6 months post-intervention.
Main Results:
- No participants dropped out of the study by the 6-month follow-up.
- A significant decrease in depressive symptoms was observed (p < .001).
- 73% of participants frequently utilized the Self-Regulated Illness Management of Depression intervention.
Conclusions:
- The Self-Regulated Illness Management of Depression intervention is a feasible and useful approach for managing recurrent depression.
- The intervention demonstrates potential for sustained engagement and symptom reduction.
- Metacognition and self-regulation strategies can be effectively integrated into depression management programs.
Related Concept Videos
Long-term Depression
33.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.3K
Long-term Depression
3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.4K
Freezing Point Depression and Boiling Point Elevation
40.4K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.4K
Depressants
462
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
462
Depression: Overview
932
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
932
Epigenetic Regulation
33.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.9K

